A Novel Platform for Localized Intratumoral Expression Of Immunotherapy: GET IT

Time: 9:30 am
day: Day Two


  • See why gene electrotransfer immunotherapy is a new platform with potential for tumor-localized expression of cytokines and low toxicity
  • Understand how cytokines are a promising adjuvant to checkpoint inhibition
  • Reveal how plasmid IL-12 (TAVO) has demonstrated activity in advanced melanoma and TNBC